Stocks · NASDAQ · Healthcare · United States
REGN — Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc (REGN) is a healthcare stock listed on NASDAQ (United States). At the close of September 29, 2026 it traded at 750.51 (-0.23% on the day), -6.1% over one month, +20.3% over three months, +34.5% over twelve months. The InvestMuse composite score is +46 on a −100 to +100 scale, a bullish read that ranks #202 of about 1,221 assets. The strongest of its nine dimensions are Fundamentals (+77) and Sector edge (+41); the weakest is Trend (-22). Its volatility regime from the hidden Markov model is Calm. 63 news articles in the last 30 days carried an average tone of +0.03 (on −1 to +1).
The facts
| Last close | 750.51 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -0.23% / -6.1% / +20.3% / +34.5% |
| 52-week range | 554.88 – 852.03 |
| Composite score | +46 / 100 · bullish view · rank #202 |
| Volatility regime (HMM) | Calm |
| Resistance levels | 515.00, 620.00, 780.00 |
| Trailing P/E | 15.4 |
| Market cap | $66.6B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)0
- Technical indicators+25
- Trend-22
- Support / resistance0
- Fundamentals+77
- Sector edge+41
- News sentiment0
- Momentum+6
- Chart patterns and zones0
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.